Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of FCγRIIIA and FCγRIIA Receptor Polymorphisms in Cetuximab Activity Used in Palliative Treatment of Upper Aerodigestive Tract Tumours

NCT01827956 is registered in ClinicalTrials.gov with Institut Bergonié as lead sponsor.

NCT NCT01827956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01827956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of FCγRIIIA and FCγRIIA Receptor Polymorphisms in Cetuximab Activity Used in Palliative Treatment of Upper Aerodigestive Tract Tumours
Lead sponsor
Institut Bergonié
Phase
Observational
Overall status
Completed
Start date
August 31, 2009
Completion date
December 31, 2013
Enrollment
121 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

upper gingival squamous cell carcinoma